五洲医疗股价涨5.37%，诺安基金旗下1只基金位居十大流通股东，持有32.79万股浮盈赚取82.63万元

Group 1 - The core viewpoint of the news is that Wuzhou Medical has seen a stock price increase of 5.37%, reaching 49.45 CNY per share, with a total market capitalization of 3.363 billion CNY [1] - Wuzhou Medical, established on April 15, 2011, specializes in the research, production, and sales of disposable sterile infusion medical devices, primarily using an ODM and integrated supply model to meet the procurement needs of foreign medical device brands [1] - The main revenue composition of Wuzhou Medical includes: 41.29% from syringes, 25.51% from medical puncture needles, 20.92% from infusion and blood transfusion devices, and 12.28% from other products [1] Group 2 - From the perspective of the top ten circulating shareholders, the Noan Fund holds a significant position, with its Noan Multi-Strategy Mixed A fund increasing its holdings by 181,600 shares in the second quarter, now holding 327,900 shares, which is 1.78% of the circulating shares [2] - The Noan Multi-Strategy Mixed A fund has achieved a year-to-date return of 61.5%, ranking 305 out of 8161 in its category, and an annual return of 85.65%, ranking 98 out of 8015 [2]